老虎证券

BUZZ-Hoth Therapeutics rises as early obesity‑drug data in mice shows promise

Reuters
02/10
BUZZ-<a href="https://laohu8.com/S/HOTH">Hoth Therapeutics</a> rises as early obesity‑drug data in mice shows promise

** Shares of Hoth Therapeutics HOTH.O rise 3.9% to $0.89 premarket

**  Co says its experimental obesity drug HT‑VA GDNF helped mice gain less weight and stabilize weight compared with semaglutide

** Co says the drug also improved blood sugar and reduced liver weight, which could help fatty liver disease — a liver condition linked to obesity

** The 12‑week study was conducted in female mice placed on a high‑fat diet, in collaboration with the U.S. Veterans Administration

** Co says it plans to start human trials in 2027 and is also developing treatments for cancer‑related skin problems and Alzheimer’s

** Shares up ~32% in 2025

(Reporting by Sahil Pandey in Bengaluru)

((Sahil.Pandey@thomsonreuters.com))

应版权方要求，你需要登录查看该内容

免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10